Ulotaront for schizophrenia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Feb 2025: Trial started, NCT06894212
  2. 25 Mar 2025: Trial registered, NCT06894212

The trials

NCT06894212: A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

State
Under way
Phase
Phase 3
People
538 taking part
Started
28 Feb 2025
Primary completion
20 Oct 2026
Arms
SEP-363856 75 mg, SEP-363856 100 mg
Results
None posted
  1. 28 Feb 2025: Trial started
  2. 25 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.